Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

Interstitial lung disease (ILD) is one of the most serious complications of rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept (ABA) in patients with ILD associated to RA.

Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Carlos Fern ández-Díaz, Javier Loricera, Santos Castañeda, Raquel López-Mejias, Clara Ojeda-Garcia, Alejandro Olivé, Samantha Rodríguez-Muguruza, Patricia E. Carreira, Trinidad Pérez-Sandoval, Miriam Retuerto, Evelin C. Cervantes Pérez, Bryan J. F Source Type: research